CNTX Context Therapeutics Inc. Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
21:39
Aug 22
Aug 22
The author defends their biotech competition picks.
The author defends their biotech competition picks, noting CNTX and TENX went to zero but frames this as expected risk in a high-upside game, not a current position or trade call.
18:29
Mar 15
Mar 15
The author provides a routine portfolio update detailing additions, reductions.
The author provides a routine portfolio update detailing additions, reductions, and closures across various biotech stocks.
21:21
Jan 05
Jan 05
Buy CNTX as a speculative biotech long; author nominates it as a top upside pick based on two.
Buy CNTX as a speculative biotech long; author nominates it as a top upside pick based on two anticipated 2026 clinical readouts expected to mirror the high-impact 2025 CTMX catalyst event.
MED
About CNTX Analyst Coverage
Buzzberg tracks CNTX (Context Therapeutics Inc.) across 2 sources. 1 bullish vs 0 bearish calls from 2 analysts. Sentiment: predominantly bullish (33%). 3 total trade ideas tracked. Latest voices: A May MD, seedy19tron.